Almirall SA at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Good morning, good afternoon, everyone. My name is Krishna Chaitanya Arikatla or K.C. Arikatla, and I cover European mid-cap pharma and life sciences companies for Goldman Sachs. It's my pleasure to have Mike McClellan CFO of Almirall; and Pablo Divasson, Head of Investor Relations at Almirall with us today.
In terms of the format for the session, it would be pretty interactive with Q&A starting right away. If you have any questions, please input your questions on the interface that you have on the right side, and I'll do my best efforts to ask those questions to management.
Questions & Answers
Now moving on to questions, Mike, on 2021 guidance, you've had a very strong Q1, with good performance across all the key growth drivers. How should we think about the guidance in that context? Do you think it's quite conservative? And how should we think about a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
